And with that increasing complexity come rising costs and the risk of delays that can slow the delivery of critical medicines to patients awaiting treatments – and flatten drug sponsors’ return on ...
INCOG BioPharma Services has announced an injectable drug manufacturing expansion at its Fishers facility in Indiana, US.
In mid-November, to boost domestic drug product manufacturing of its own, Moderna announced 3 a new $140 million investment ...
Partnership creates simplified pathway from early development to commercial launch to deliver seamless, end-to-end oral solid ...
New addition enhances manufacturing continuity and supports seamless progression from early-phase development to late-stage ...
Capital Market on MSN
Shelter Pharma gains after securing international D3 cure capsules order
The order is a fixed-cost contract and is to be executed within two months. The company said neither its promoters nor group ...
Mayne Pharma Group ( ($AU:MYX) ) has provided an update. Mayne Pharma has officially opened its expanded manufacturing facility in Salisbury, ...
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On ...
Global trade is becoming markedly more complex, driven by decentralised production, heightened demand volatility and far ...
Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry averages. This ...
The pharmaceuticals segment accounts for 61.4% of market share in 2025, emphasizing its reliance on sterile water systems for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback